SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-213473
Filing Date
2023-08-15
Accepted
2023-08-15 16:27:54
Documents
12
Period of Report
2023-08-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d538227d8k.htm   iXBRL 8-K 22087
  Complete submission text file 0001193125-23-213473.txt   146624

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA etnb-20230810.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20230810_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20230810_pre.xml EX-101.PRE 11703
6 EXTRACTED XBRL INSTANCE DOCUMENT d538227d8k_htm.xml XML 3464
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 231175239
SIC: 2834 Pharmaceutical Preparations